Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
SCWorx Corp is a health information services business based in the US. SCWorx shares (WORX) are listed on the NASDAQ and all prices are listed in US Dollars. SCWorx employs 4 staff and has a trailing 12-month revenue of around USD$5 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$1 - USD$9.9 |
---|---|
50-day moving average | USD$2.0921 |
200-day moving average | USD$1.6544 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-1.269 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$5 million |
---|---|
Gross profit TTM | USD$1.2 million |
Return on assets TTM | -57.01% |
Return on equity TTM | -172.98% |
Profit margin | -229.25% |
Book value | $0.499 |
Market capitalisation | USD$22.2 million |
TTM: trailing 12 months
There are currently 870,847 SCWorx shares held short by investors – that's known as SCWorx's "short interest". This figure is 6.8% up from 815,654 last month.
There are a few different ways that this level of interest in shorting SCWorx shares can be evaluated.
SCWorx's "short interest ratio" (SIR) is the quantity of SCWorx shares currently shorted divided by the average quantity of SCWorx shares traded daily (recently around 2.4 million). SCWorx's SIR currently stands at 0.37. In other words for every 100,000 SCWorx shares traded daily on the market, roughly 370 shares are currently held short.
However SCWorx's short interest can also be evaluated against the total number of SCWorx shares, or, against the total number of tradable SCWorx shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SCWorx's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 SCWorx shares in existence, roughly 90 shares are currently held short) or 0.0998% of the tradable shares (for every 100,000 tradable SCWorx shares, roughly 100 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SCWorx.
Find out more about how you can short SCWorx stock.
We're not expecting SCWorx to pay a dividend over the next 12 months.
SCWorx's shares were split on a 1:19 basis on 4 February 2019. So if you had owned 19 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SCWorx shares – just the quantity. However, indirectly, the new 1800% higher share price could have impacted the market appetite for SCWorx shares which in turn could have impacted SCWorx's share price.
Over the last 12 months, SCWorx's shares have ranged in value from as little as $1 up to $9.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SCWorx's is 3.7216. This would suggest that SCWorx's shares are significantly more volatile than the average for this exchange and represent a higher risk.
SCWorx Corp. provides software solutions for the management of health care providers' foundational business applications in the United States. The company provides services related to repair, normalization, and interoperability of information, as well as big data analytics model that provides Web portal for display, and reporting and analysis of the information contained within the data warehouse. It also offers various software solutions and services, such as virtualized item master file repair, expansion, and automation; electronic medical record management, a module that integrates the advanced data attributes created in the item master to the electronic medical records; charge description master management(CDM), a module, which assists healthcare providers by integrating the CDM data into the workflow of the hospitals purchasing systems; contract management, a module that assists healthcare providers to establish a contract management system and to provide care to patients; request for proposal automation solution; rebate management; ScanWorx, a mobile perioperative closed loop scanning solution; and data integration and warehousing, as well as solutions for integration of acquired businesses, which enable deployment of a virtual item master files. The company sells its solutions and services to hospitals and health systems through its distribution and reseller partnerships. In addition, it provides CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling rapid test kits for COVID-19; and personal protective equipment. SCWorx Corp. is based in New York, New York.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.